Functional Assessment
|
Flow Cytometric Analyses- CD34 Enumeration (A201)
- CD 34/CD33 Enumeration (A202)
- CD 3 Enumeration (A203)
- 7-AAD Viability Testing (A204)
- CD4/CD8 Enumeration (A205)
|
Polymer Chain Reaction- Bc1-1 Mantle Cell Lymphoma (A301)
- Bc1-2 Follicular Lymphoma (A302)
- Bcr-abl CML (A303)
- Igg Heavy Chain-MM, CLL, B-Cell Malignancies (A304)
|
Immunocytochemistry
- Breast Cancer (A401)
- Colorectal Cancer (A402)
- Esophageal Cancer (A403)
- GI Cancer (A404)
- Lung Cancer (A405)
- Ovarian Cancer (A406)
- Pancreatic Cancer (A407)
- Prostate Cancer (A408)
- Renal Cell Cancer (A409)
- Thyroid Cancer (A410)
- Epithelial Cancer (other) (A411)
- Ewing's Sarcoma (A412)
- Head & Neck Cancer (A413)
- Lymphoma/CLL (A414)
- Anti-DC 20 Monitoring (A415)
- Melanoma (A416)
- Neuroblastoma (A417)
- ICC for CD 19/CD 20 (A418)
|
Tumor Clonogenic Assay
- Breast Cancer (A501)
- Ewing's Sarcoma (A502)
- Lung Cancer (A503)
- Lymphoma (A504)
- Neuroblastoma (A505)
- Prostate Cancer (A506)
|
Additional for Tumor Cell Enrichment
- Breast Cancer (A601)
- Colorectal Cancer (A602)
- Esophageal Cancer (A603)
- GI Cancer (A604)
- Lung Cancer (A605)
- Ovarian Cancer (A606)
- Pancreatic Cancer (A607)
- Prostate Cancer (A608)
- Renal Cell Cancer (A609)
- Thyroid Cancer (A610)
- Epithelial Cancer (other) (A611)
- Lymphoma (A612)
- CLL (A613)
|
Microbial Assay- Fungal Assays (A701)
- Microbial Assay, Aerobic (A702)
- Microbial Assay, Anaerobic (A703)
|
